Toll-like receptor-mediated responses of primary intestinal epithelial cells during the development of colitis

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 288, Issue 3 51-3, 2005, Pages

  Singh, Joy Carmelina Indira ^a   Cruickshank, Sheena Margaret ^a   Newton, Darren James ^a   Wakenshaw, Louise ^a   Graham, Anne ^b   Lan, Jinggang ^a   Lodge, Jeremy Peter Alan ^a   Felsburg, Peter John ^c   Carding, Simon Richard ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

^c UNIVERSITY OF PENNSYLVANIA SCHOOL OF VETERINARY MEDICINE   (United States)

Author keywords

Colon; Ulcerative colitis

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 2; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLON MUCOSA; CONTROLLED STUDY; ENZYME ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, DIFFERENTIATION; BACTERIA; BLOTTING, WESTERN; CASPASE 1; CELL SEPARATION; CELLS, CULTURED; COLITIS; DNA, COMPLEMENTARY; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; FLOW CYTOMETRY; INTERLEUKIN-18; INTESTINES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MYELOID DIFFERENTIATION FACTOR 88; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS; UP-REGULATION;

EID: 13844312846     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00377.2004     Document Type: Article

References (67)

1. Abreu MT, Arnold ET, Thomas LS, Gonsky R, Zhou Y, Hu B, and Arditi M. TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J Biol Chem 111: 20431-20437, 2002.
2. Abreu MT, Vora P, Faure E, Thomas LS, Arnold ET, and Arditi M. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol 167: 1609-1616, 2001.
3. Aderem A. Role of Toll-like receptors in inflammatory response in macrophages. Crit Care Med 29: S16-S18, 2001.
4. Aderem A and Ulevitch RJ, Toll-like receptors in the induction of innate immunity. Nature 406: 728-787, 2000.
5. Akashi S, Ogata H, Kirikae F, Kirikae T, Kawasaki K, Nishijima M, Shimazu R, Nagai Y, Fukudome K, Kimoto M, and Miyake K. Regulatory roles for CD14 and phosphotidylinositol in the signaling via Toll-like receptor 4-MD-2. Biochem Biophys Res Commun 268: 172-177, 2000.
6. Akira S. Toll-like receptors: lessons from knockout mice. Biochem Soc Trans 28: 551-556, 2000.
7. Akira S. Toll-like receptors and innate immunity. Adv Immunol 78: 1-56, 2001.
8. Akira S. Toll-like receptor signaling. J Biol Chem 278: 38105-38108, 2003.
9. Akira S, Takeda K, and Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immun 2: 675-680, 2001.
10. Andoh A, Kinoshita K, Rosenberg I, and Podolsky DK. Intestinal trefoil factor induces decay-accelerating factor expression and enhances the protective activities against complement activation in intestinal epithelial cells. J Immunol 167: 3887-3893, 2001.
11. Ashcroft A, Cruickshank SM, Croucher PI, Perry MJ, Rollinson S, Lippitt JM, Child JA, Dunstan C, Felsburg PJ, Morgan GJ, and Carding SR. Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin. Immunity 19: 849-861, 2003.
12. Baumgart DC, Olivier WA, Reya T, Peritt D, Rombeau JL, and Carding SR. Mechanisms of intestinal epithelial cell injury and colitis in interleukin 2 (IL-2)-deficient mice. Cell Immunol 187: 52-66, 1998.
13. Bocker U, Yezerskyy O, Feick P, Manigold T, Panja A, Kalina U, Herweck F, Rossol S, and Singer MV. Responsiveness of intestinal epithelial cell lines to lipopolysaccharide is correlated with Toll-like receptor 4 but not Toll-like receptor 2 or CD14 expression. Int J Colorectal Dis 18: 25-32, 2003.
14. Cario E, Brown D, McKee M, Lynch-Devaney K, Gerken G, and Podolsky DK. Commensal-associated molecular patterns induce selective Toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium. Am J Pathol 160: 165-173, 2002.
15. Cario E, Rosenberg IM, Brandwein SL, Beck PL, Reinecker HC, and Podolsky DK. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol 164: 966-972, 2000.
16. Conti P and DiGioacchino M. MCP-1 and RANTES are mediators of acute and chronic inflammation. Allergy Asthma Proc 22: 133-137, 2001.
17. Contractor NV, Bassiri H, Reya T, Park AV, Baumgart DC, Wasik M, Emerson SG, and Carding SR. Lymphoid hyperplasia, autoimmunity and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic interleukin 2-deficient mice. J Immunol 160: 385-394, 1998.
18. Dangl JL and Jones JDG. Plant pathogens and integrated defence responses to infection. Nature 411: 826-833, 2001.
19. Didierlaurent A, Sirard JC, Kraehenbuhl JP, and Neutra MR. How the gut senses its content. Cell Microbiol 4: 61-72, 2002.
20. Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, and Meyer Zum Buschenfelde K-H. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 102: 448-455, 1995.
21. Duchmann R, May E, Heike M, Knolle P, Neurath M, and Meyer zum Buschenfelde K-H. T cell specificity and cross reactivity towards enterobacteria, Bacteriodes, Bifidobacterium, and antigens from resident intestinal flora. Gut 44: 812-818, 1999.
22. Fusunyan RD, Nanthakumar NN, Baldeon ME, and Walker WA. Evidence for an innate immune response in the immature human intestine: toll-like receptors on fetal enterocytes. Pediatr Res 49: 589-593, 2001.
23. Grossmann RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, May LT, Kupper TS, Seghal BL, and Gottlieb AB. Interleukin-6 is expressed in high levels in psoriasis skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 86: 6367-6371, 1989.
24. Gu L, Rutledge B, Fiorillo J, Ernst C, Grewal I, Flavell R, Gladue R, and Rollins B. In vivo properties of monocyte chemoattractant protein-1. J Leukoc Biol 62: 577-580, 1997.
25. Hampe J, Cuthbert A, Croucher PJP, Mirza MM, Mascheretti S, Fisher S, Frenzel H, King K, Hasselmeyer A, MacPherson AJS, Bridger S, van Deventer S, Forbes A, Nikolaus S, Lennard-Jones JE, Foelsch UR, Krawczak M, Lewis C, Schreiber S, and Mathew CG. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357: 1925-1928, 2001.
26. Hibi M, Nakajima K, and Hirano T. IL-6 cytokine family and signal transduction: a model of the cytokine system. J Mol Med 74: 1-12, 1996.
27. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Aimer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, and Thomas G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-603, 2001.
28. Inan MS, Tolmacheva V, Wang QS, Rosenberg D, and Giardina C. Transcription factor NF-κB participates in regulation of epithelial cell turnover in the colon. Am J Physiol Gastrointest Liver Physiol 279: G1282-G1291, 2000.
29. Inohara N, Ogura Y, and Nunez G. Nods: a family of cytosolic proteins that regulates the host responses to pathogens. Curr Opin Microbiol 5: 76-80, 2002.
30. Irie T, Muta T, and Takeshige K. TAK1 mediates an activation signal from toll-like receptor(s) to nuclear factor-κB in lipopolysaccharide- stimulated macrophages. FEBS Lett 467: 160-164, 2000.
31. Kaisho T and Akira S. Dendritic-cell function in Toll-like receptor and MyD88 knockout mice. Trends Immunol 22: 78-83, 2001.
32. Kanai T, Watanabe M, Okazawa A, Sato T, and Hibi T. Interleukin-18 and Crohn's disease. Digestion 63: 37-42, 2001.
33. Kawai T, Takeuchi O, Fujita T, Inoue J, Muhlradt PF, Sato S, Hoshino K, and Akira S. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 167: 5887-5894, 2001.
34. Kishimoto T, Akira S, Narazaki M, and Taga T. Interleukin-6 family of cytokines and gp130. Blood 86: 1243-1254, 1995.
35. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4 from random aggregation. Nature 47: 69-85, 1970.
36. Low QE, Drugea IA, Duffner LA, Quinn DG, Cook DN, Rollins BJ, Kovacs EJ, and DiPietro LA. Wound healing in MIP-1α(-/-) and MCP-1(-/-) mice. Am J Pathol 159: 457-463, 2001.
37. Malik AA, Radhakrishnan N, Reddy K, Smith AD, and Singhal PC. Tubular cell-Escherichia coli interaction products modulate migration of monocytes through generation of transforming growth factor-β and macrophage-monocyte chemoattractant protein-1. J Endourol 16: 599-603, 2002.
38. Matsuda H, Fujiyama Y, Andoh A, Ushijima T, Kajinami T, and Bamba T. Characterization of antibody responses against rectal mucosa-associated bacterial flora in patients with ulcerative colitis. J Gastroenterol Hepatol 15: 61-68, 2000.
39. McGee D. Inflammation and mucosal cytokine production. In: Mucosal Immunology, edited by Ogra P, Mestecky J, Lamm ME, Strober W, Bienenstock J, and McGhee JR. San Diego, CA: Academic, 1999, p. 559-573.
40. Means TK, Golenbock DT, and Fenton MJ. The biology of Toll-like receptors. Cytokines Growth Factor Rev 11: 219-232, 2000.
41. Melmed G, Thomas LS, Lee N, Tesfay SY, Lukasek K, Michelsen KS, Zhou Y, Hu B, Arditi M, and Abreu MT. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J Immunol 170: 1406-1415, 2003.
42. Morr M, Takeuchi O, Akira S, Simon MM, and Muhlradt PF. Differential recognition of structural details of bacterial lipopeptides by toll-like receptors. Eur J Immunol 32: 3337-3347, 2002.
43. Mukaida N, Harada A, and Matsushima K. Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions. Cytokine Growth Factor Rev 9: 9-23, 1998.
44. Muzio M, Natoli G, and Saccani S. The human toll signaling pathway: divergence of nuclear factor κB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J Exp Med 187: 2097-2101, 1998.
45. Naik S, Kelly EJ, Meijer L, Pettersson T, and Sanderson IR. Absence of Toll-like receptor 4 explains endotoxin hyporesponsiveness in human intestinal epithelium. J Pediatr Gastroenterol Nutr 32: 449-453, 2001.
46. Naka T, Nishimoto N, and Kishimoto T. The paradigm of IL-6: from basic science to medicine. Arthritis Res 4: S233-S242, 2002.
47. Prindiville T, Sheikh R, and Cohen S. Bacteriodes fragilis enterotoxin gene sequences in patients with inflammatory bowel diseases. Emerg Infect Dis 6: 171-174, 2000.
48. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, and Medzhitov R. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118: 229-241, 2004.
49. Rogler G, Brand K, Vogl S, Page R, Hofmeister T, Andus T, Knuechel R, Baeuerle PA, Scholmerich J, and Gross V. Nuclear factor-κB is activated in macrophages and epithelial cells of inflammed mucosa. Gastroenterology 115: 357-369, 1998.
50. Rollins BJ. Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease. Mol Med Today 2: 198-204, 1996.
51. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, and Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75: 253-261, 1993.
52. Schorle H, Holtschke T, Hunig T, Schimpl A, and Horak I. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352: 621-624, 1991.
53. Seigmund B. Interleukin-1β converting enzyme (caspase-1) in intestinal inflammation. Biochem Pharmacol 64: 1-8, 2002.
54. Seigmund B, Fantuzzi G, Rieder F, Gamboni-Robertson F, Lehr HA, Hartmann G, Dinarello CA, Endres S, and Eigler A. Neutralisation of interleukin-18 reduces severity in murine colitis and intestinal IFN-γ and TNF-α production. Am J Physiol Regul Integr Comp Physiol 281: R1264-R1273, 2001.
55. Siegmund B, Lehr HA, Fantuzzi G, and Dinarello CA. IL-1β converting enzyme (caspase-1) in intestinal inflammation. Proc Natl Acad Sci USA 98: 13249-13254, 2001.
56. Seki E, Tsutsui H, Nakano H, Tsuji NM, Hoshino K, Adachi O, Adachi K, Futatsugi S, Kuida K, Takeuchi O, Okamura H, Fujimoto J, Akira S, and Nakanishi K. Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1β. J Immunol 166: 2651-2657, 2001.
57. Shephard RJ. Cytokine responses to physical activity, with particular reference to IL-6: sources, actions, and clinical implications. Crit Rev Immunol 22: 165-182, 2002.
58. Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K, and Kimoto M. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 189: 1777, 1999.
59. Sweet MJ, Campell CC, Sester DP, Xu D, McDonald RC, Stacey KJ, Hume DA, and Liew FY. Colony-stimulating factor-1 suppresses responses to CpG DNA and expression of Toll-like receptor but enhances responses to lipopolysacharide in murine macrophases. J Immunol 168: 392-399, 2002.
60. Telega G, Baumgart DB, and Carding SR. Uptake and presentation of antigen to T cells by primary colonic epithelial cells in normal and diseased states. Gastroenterology 119: 1548-1559, 2000.
61. Ten Hove T, Corbaz A, Amitai H, Aloni S, Belzer I, Graber P, Drillenburg P, Van Deventer SJH, Chvatchko Y, and Te Velde AA. Blockade of endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNF-α production in mice. Gastroenterology 121: 1372-1379, 2001.
62. Traynor TR, Herring AC, Dorf ME, Kuziel WA, Toews GB, and Huffnagle GB. Differential roles of CC chemokine ligand 2/monocyte chemotactic protein-1 and CCR2 in the development of T1 immunity. J Immunol 168: 4659-4666, 2002.
63. Vidrich A, Ravindranath R, Farsi K, and Targan S. A method for the rapid establishment of normal adult mammalian colonic epithelial cell cultures. In Vitro Cell Dev Biol 24: 188-194, 1988.
64. Wald D, Qin J, Zhao Z, Qian Y, Naramura M, Tian L, Towne J, Sims JE, Stark GR, and Li X. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat Immun 4: 920-927, 2003.
65. Wantanabe T, Kitani A, Murray PJ, and Strober W. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immun 5: 800-808, 2004.
66. Wirtz S, Becker C, Blumberg R, Galle PR, and Neurath MF. Treatment of T cell-dependent experimental colitis in SCID mice by local administration of an adenovirus expressing IL-18 antisense mRNA. J Immunol 168: 411-420, 2002.
67. Yoshizaki K, Nishimoto N, Matsumoto K, Tagoh U, Taga T, Deguchi Y, Kuritani T, Hirano T, and Kishimoto T. Interleukin-6 and its receptor expression on the epidermal keratinocytes. Cytokine 2: 381-387, 1990.